THR-009

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameTHR-009

Drug Alias NameALK-3 receptor agonist (Thrasos)BMP-TGFbeta peptidomimetic (Thrasos)TGF-beta antagonist (Thrasos)activin-receptor-like kinase 3 receptor agonist (Thrasos)bone morphogenetic protein-transforming growth factor beta pepdiomimetic (Thrasos) +[6]

ClassificationSmall molecules > Peptidomimetic

Mechanisms of ActionBone morphogenetic protein receptor type-1A stimulants

TargetsBone morphogenetic protein receptor type-1A

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesThrasos Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThrasos Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsInflammation

Other Information

ATC CodeN/A